Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Find out more about the MS-UK Helpline

Find out more about our Choices booklets

Find out more about New Pathways magazine

 


Researchers have discovered a gene involved in deregulation of certain immune cells in multiple sclerosis. Characterised by the onset of chronic, neurodegenerative damage of the central nervous...
A recent study has found that Andrographis paniculata (A. paniculata), or green chiretta reduces fatigue in patients with relapsing-remitting MS (RRMS) who are also receiving beta interferon,...
For the first time scientists have been able to demonstrate a correlation between the blood coagulation system and the development of multiple sclerosis (MS), the University of Duisburg-Essen has...
New evidence suggests a diet mimicking the effects of fasting has health benefits beyond weight loss, with a USC-led study indicating it may reduce symptoms of multiple sclerosis. Scientists...
The Yissum Research Development Company, an arm of Hebrew University of Jerusalem, has entered into an agreement with Aurum Ventures MKI to develop a diagnostic blood test for relapsing-remitting...
Scorpions, snakes, snails, frogs and other creatures are thought to produce tens or even hundreds of millions of distinct venoms. These venoms have been honed to strike specific targets in the body....
This World MS Day the MS International Federation has released a report, based on a global survey, which highlights the need for reasonable adjustments to help people with MS continue working. The...
A mutation in a mouse model of the John Cunningham (JC) virus, which causes progressive multifocal leukoencephalopathy (PML), allows the virus to evade the host immune responses in people with...
It has been reported that patient who developed progressive multifocal leukoencephalopathy (PML) after natalizumab therapy, found the immune-boosting molecule interleukin-2 (IL-2) helped tackle this...
People in Orkney have higher levels of vitamin D than people on mainland Scotland, a study has suggested. Low vitamin D levels have previously been put forward as a reason for Orkney having one of...

Pages